Continuous Subcutaneous Insulin Infusion
Also known as: CSII, Insulin Pump Therapy
See Insulin Pump — the clinical term for pump-based insulin delivery directly into the subcutaneous tissue.
Continuous subcutaneous insulin infusion (CSII) is the clinical term for insulin pump therapy. It involves the continuous delivery of rapid-acting insulin into the subcutaneous tissue through a cannula, at programmed basal rates plus user-initiated boluses.
CSII is the most physiologically accurate insulin delivery method available outside of islet cell transplantation. It allows fine-tuned basal rate programming, multiple daily basal profiles, varied bolus delivery patterns, and — in closed-loop systems — real-time automated adjustments.
For Medicare coverage purposes, CSII is the terminology used in the National Coverage Determination for insulin infusion pumps (Medicare NCD 280.14). The documentation requirements, C-peptide thresholds, and clinical criteria are specified in this NCD.
Frequently asked
What is Continuous Subcutaneous Insulin Infusion?
See Insulin Pump — the clinical term for pump-based insulin delivery directly into the subcutaneous tissue. Continuous subcutaneous insulin infusion (CSII) is the clinical term for insulin pump therapy. It involves the continuous delivery of rapid-acting insulin into the subcutaneous tissue through a cannula, at programmed basal rates plus user-initiated boluses.
How does Continuous Subcutaneous Insulin Infusion relate to Medicare coverage?
Medicare Part B covers most durable medical equipment related to Continuous Subcutaneous Insulin Infusion. Contact us to verify your specific coverage for related diabetic supplies.
Where can I get diabetic supplies related to Continuous Subcutaneous Insulin Infusion in Phoenix?
We deliver Medicare-covered diabetic supplies throughout the Phoenix metro area. Call us or complete the form above to verify your coverage.